litlas
ログインアカウント作成

Guido Rindi

1961–2025 年に発表

127
論文数
27,392
被引用数
82
h 指数
124
i10 指数

被引用数

Guido Rindi の年別被引用数1969 年: 被引用 1 件1979 年: 被引用 2 件1983 年: 被引用 1 件1984 年: 被引用 2 件1985 年: 被引用 1 件1986 年: 被引用 4 件1987 年: 被引用 11 件1988 年: 被引用 7 件1989 年: 被引用 13 件1990 年: 被引用 11 件1991 年: 被引用 18 件1992 年: 被引用 10 件1993 年: 被引用 24 件1994 年: 被引用 16 件1995 年: 被引用 13 件1996 年: 被引用 19 件1997 年: 被引用 11 件1998 年: 被引用 21 件1999 年: 被引用 39 件2000 年: 被引用 50 件2001 年: 被引用 36 件2002 年: 被引用 28 件2003 年: 被引用 40 件2004 年: 被引用 86 件2005 年: 被引用 70 件2006 年: 被引用 84 件2007 年: 被引用 93 件2008 年: 被引用 134 件2009 年: 被引用 124 件2010 年: 被引用 208 件2011 年: 被引用 222 件2012 年: 被引用 227 件2013 年: 被引用 156 件2014 年: 被引用 189 件2015 年: 被引用 180 件2016 年: 被引用 197 件2017 年: 被引用 231 件2018 年: 被引用 191 件2019 年: 被引用 781 件2020 年: 被引用 823 件2021 年: 被引用 675 件2022 年: 被引用 471 件2023 年: 被引用 380 件2024 年: 被引用 578 件2025 年: 被引用 190 件2026 年: 被引用 3 件1970〜1978 年は被引用が無いため表示していません1980〜1982 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,419 件、この内訳の 19.7%イタリア: 引用元論文 862 件、この内訳の 12%ドイツ: 引用元論文 541 件、この内訳の 7.5%イギリス: 引用元論文 465 件、この内訳の 6.4%フランス: 引用元論文 416 件、この内訳の 5.8%中国: 引用元論文 410 件、この内訳の 5.7%オランダ: 引用元論文 319 件、この内訳の 4.4%日本: 引用元論文 261 件、この内訳の 3.6%スウェーデン: 引用元論文 239 件、この内訳の 3.3%カナダ: 引用元論文 217 件、この内訳の 3%スイス: 引用元論文 197 件、この内訳の 2.7%スペイン: 引用元論文 194 件、この内訳の 2.7%
0%19.7%その他 23.2%

機関

分野

  • Medicine87.5%
  • Biochemistry, Genetics and Molecular Biology5.1%
  • Neuroscience3.3%
  • Engineering1.2%
  • Immunology and Microbiology0.8%
  • Nursing0.7%
  • その他1.4%

トピック

  • Neuroendocrine Tumor Research Advances20.5%
  • Lung Cancer Research Studies13.1%
  • Neuroblastoma Research and Treatments7.7%
  • Pancreatic and Hepatic Oncology Research6.9%
  • Thyroid Cancer Diagnosis and Treatment2.3%
  • Gastrointestinal Tumor Research and Treatment2.3%
  • その他47.2%

共著者

全論文

検索で開く
  1. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

    著者: Guido Rindi, Özgür Mete, Silvia Uccella, Olca Baştürk, Stefano La Rosa, Lodewijk A.A. Brosens, Shereen Ezzat, Wouter W. de Herder, David S. Klimstra, Mauro Papotti, L. Sylvia - Endocrine Pathology 2022 被引用: 957

  2. Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

    著者: Martyn Caplin, Marianne Pavel, Jarosław B. Ćwikła, Alexandria T. Phan, Markus Raderer, Eva Sedláčková, Guillaume Cadiot, Edward M. Wolin, Jaume Capdevila, Lucy Wall, Guido Rindi, Alison Langley, Séverine Martinez, Joëlle Blumberg, Philippe Ruszniewski - New England Journal of Medicine 2014 被引用: 1,925

  3. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal

    著者: Guido Rindi, David S. Klimstra, Behnoush Abedi‐Ardekani, L. Sylvia, Fred T. Bosman, Élisabeth Brambilla, Klaus J. Busam, Ronald R. de Krijger, Manfred Dietel, Adel K. El‐Naggar, Lynnette Fernandez‐Cuesta, Günter Klöppel, W. Glenn McCluggage, Holger Moch, Hiroko Ohgaki, Emad A. Rakha, Nicholas Reed, Brian Rous, Hironobu Sasano, Aldo Scarpa, Jean‐Yves Scoazec, William D. Travis, Giovanni Tallini, Jacqueline Trouillas, J. Han van Krieken, Ian A. Cree - Modern Pathology 2018 被引用: 1,125

  4. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

    著者: Massimo Falconi, Barbro Eriksson, Gregory Kaltsas, Detlef K. Bartsch, Jaume Capdevila, Martyn Caplin, Beata Kos‐Kudła, Dik J. Kwekkeboom, Guido Rindi, Günter Klöppel, Nicholas S. Reed, Réza Kianmanesh, Robert T. Jensen, all other Vienna Consensus Conference participants - Neuroendocrinology 2016 被引用: 1,362

  5. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

    著者: M. Caplin, Éric Baudin, Piero Ferollà, Pier Luigi Filosso, Mariano Garcı́a-Yuste, Eric Lim, Kjell Öberg, Giuseppe Pelosi, Aurel Perren, Roberta Rossi, William D. Travis, D.K. Bartsch, Jaume Capdevila, Frederico Costa, Jarosław B. Ćwikła, Wouter W. de Herder, Gianfranco Delle Fave, Barbro Eriksson, Massimo Falconi, Diego Ferone, David J. Gross, Ashley Grossman, Tetsuhide Ito, Robert T. Jensen, Gregory Kaltsas, Fahrettin Keleştimur, Réza Kianmanesh, Ulrich Knigge, Beata Kos‐Kudła, Eric P. Krenning, Emmanuel Mitry, M. Nicolson, Juan Manuel O’Connor, Dermot O’Toole, Ulrich-Frank Pape, Marianne Pavel, John Ramage, Éric Raymond, Guido Rindi, Andrea Rockall, Philippe Ruszniewski, Ramón Salazar, Aldo Scarpa, Eva Sedláčková, Anders Sundin, Christos Toumpanakis, Marie‐Pierre Vullierme, Wolfgang Weber, Bertram Wiedenmann, Zeng Zheng-Pei - Annals of Oncology 2015 被引用: 699

  6. Gastroenteropancreatic neuroendocrine tumours

    著者: Irvin M. Modlin, Kjell Öberg, Daniel C. Chung, Robert T. Jensen, Wouter W. de Herder, Rajesh V. Thakker, Martyn Caplin, Gianfranco Delle Fave, Gregory Kaltsas, Eric P. Krenning, Steven F. Moss, Ola Nilsson, Guido Rindi, Ramón Salazar, Philippe Ruszniewski, Anders Sundin - The Lancet Oncology 2008 被引用: 1,752

  7. European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for colorectal neuroendocrine tumours

    著者: Anja Rinke, Valentina Ambrosini, Clarisse Dromain, Rocio García‐Carbonero, Amyn Haji, Anna Koumarianou, Els Nieveen van Dijkum, Dermot O’Toole, Guido Rindi, Jean‐Yves Scoazec, John Ramage - Journal of Neuroendocrinology 2023 被引用: 147

  8. Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response

    著者: Sabrina Chiloiro, Antonella Giampietro, Federica Mirra, Federico Donfrancesco, Tommaso Tartaglione, Pier Paolo Mattogno, Flavia Angelini, Liverana Lauretti, Marco Gessi, Carmelo Anile, Guido Rindi, Andrea Giustina, Maria Fleseriu, Alfredo Pontecorvi, Laura De Marinis, Antonio Bianchi - European Journal of Endocrinology 2020 被引用: 55

  9. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

    著者: Guido Rindi, G. Klöppel, H. Alhman, Martyn Caplin, Anne Couvelard, Wouter W. de Herder, B. Erikssson, Alberto Falchetti, Massimo Falconi, Paul Komminoth, Meike Körner, José Manuel Lopes, A. M. McNicol, Ola Nilsson, Aurel Perren, Aldo Scarpa, J-Y. Scoazec, Bertram Wiedenmann, and all other Frascati Consensus Conference participants - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2006 被引用: 1,572

  10. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification

    著者: Aurel Perren, Anne Couvelard, Jean‐Yves Scoazec, Frederico Costa, Ivan Borbath, Gianfranco Delle Fave, Vera Gorbounova, David J. Gross, Ashley Grossman, Robert T. Jensen, Matthew H. Kulke, Kjell Öberg, Guido Rindi, Halfdan Sørbye, Staffan Welin, all other Antibes Consensus Conference participants - Neuroendocrinology 2017 被引用: 248

  11. Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study

    著者: Donato Iacovazzo, Eivind Carlsen, Francesca Lugli, Sabrina Chiloiro, Serena Piacentini, Antonio Bianchi, Antonella Giampietro, Marilda Mormando, Andrew Clear, Francesco Doglietto, Carmelo Anile, Giulio Maira, Libero Lauriola, Guido Rindi, Federico Roncaroli, Alfredo Pontecorvi, Márta Korbonits, Laura De Marinis - European Journal of Endocrinology 2016 被引用: 159

  12. Pembrolizumab as first-line treatment for metastatic uveal melanoma

    著者: Ernesto Rossi, Monica Maria Pagliara, Daniela Orteschi, Tommaso Dosa, Maria Grazia Sammarco, Carmela Grazia Caputo, Gianluigi Petrone, Guido Rindi, Marcella Zollino, Maria Antonietta Blasi, Alessandra Cassano, Emilio Bria, Giampaolo Tortora, Giovanni Schinzari - Cancer Immunology Immunotherapy 2019 被引用: 86

  13. Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study

    著者: Cédric Nesti, Konstantin Bräutigam, Marta Benavent, Laura Bernal, Hessa Boharoon, Johan Botling, B Antonin, Iva Brčić, Maximilian Brunner, Guillaume Cadiot, María Cámara, Emanuel Christ, Thomas Clerici, Ashley Kieran Clift, H.W. Clouston, Lorenzo Cobianchi, Jarosław B. Ćwikła, Kosmas Daskalakis, Andrea Frilling, Rocio García‐Carbonero, Simona Grozinsky‐Glasberg, Jorge Hernando, Valérie Hervieu, Johannes Hofland, Pernille Holmager, Frediano Inzani, Henning Jann, Paula Jiménez‐Fonseca, Enes Kaçmaz, Daniel Kaemmerer, Gregory Kaltsas, Branislav Klimàcek, Ulrich Knigge, Agnieszka Kolasińska-Ćwikła, Walter Kolb, Beata Kos‐Kudła, Catarina Alisa Kunze, Stefania Landolfi, Stefano La Rosa, Carlos López, Kerstin Lorenz, Maurice Matter, Peter Mazal, Claudia Mestre‐Alagarda, Patricia Morales del Burgo, Els J.�M. Nieveen van Dijkum, Kira Oleinikov, Lorenzo A. Orci, Francesco Panzuto, Marianne Pavel, Marine Perrier, Henrik M. Reims, Guido Rindi, Anja Rinke, Maria Rinzivillo, Xavier Sagaert, I. Satiroglu, Andreas Selberherr, Alexander Siebenhüner, Margot Tesselaar, M. Thalhammer, Espen Thiis‐Evensen, Christos Toumpanakis, Timon Vandamme, José G. van den Berg, Alessandro Vanoli, Marie‐Louise F. van Velthuysen, Chris Verslype, Stephan A. Vorburger, Alessandro Lugli, John Ramage, Marcel Zwahlen, Aurel Perren, Reto M. Kaderli - The Lancet Oncology 2023 被引用: 66

  14. Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial

    著者: Nicola Normanno, Anna Maria Rachiglio, Matilde Lambiase, Erika Martinelli, Francesca Fenizia, Ciro Esposito, Cristin Roma, Teresa Troiani, Daniele Rizzi, Fabiana Tatangelo, Gerardo Botti, Evaristo Maiello, Giuseppe Colucci, Fortunato Ciardiello, Francesco Giuliani, G. Simone, Antonio Febbraro, Eugenio Tommaselli, Saverio Cinieri, Marianna Criscuolo, A Perrino, Antonio Rinaldi, Roberto Bordonaro, M Manusia, S. Romito, Pantaleo Bufo, Giacomo Cartenì, M. Biglietto, Oscar Nappi, A. Cardarelli, E. Montesarchio, Pietro Micheli, Guglielmo Nasti, Nicoletta Chicchinelli, Alessia Iannaccone, Andrea Russo, Daniela Cabibi, P. Giaccone, Carlo Barone, Guido Rindi, Giuseppe Tonini, Andrea Onetti Muda, Giuseppe Perrone, T. Latiano, Paolo Graziano, Salvatore Pisconti, Annamaria Sebastio - Annals of Oncology 2015 被引用: 146

  15. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers

    著者: Kjell Öberg, Anne Couvelard, Gianfranco Delle Fave, David J. Gross, A. Grossman, Robert T. Jensen, Ulrich‐Frank Pape, Aurel Perren, Guido Rindi, Philippe Ruszniewski, Jean‐Yves Scoazec, Staffan Welin, Bertram Wiedenmann, Diego Ferone, all other Antibes Consensus Conference participants - Neuroendocrinology 2017 被引用: 173

  16. High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine Tumors

    著者: Johan Botling, Ángela Lamarca, D. Bajic, Olov Norlén, Vincent Lönngren, Josefine Kjaer, Barbro Eriksson, Staffan Welin, Per Hellman, Guido Rindi, Britt Skogseid, Joakim Crona - Neuroendocrinology 2019 被引用: 62

  17. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis

    著者: Giorgio Treglia, Paola Castaldi, Guido Rindi, Alessandro Giordano, Vittoria Rufini - Endocrine 2012 被引用: 265

  18. Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma

    著者: Ernesto Rossi, Brigida Anna Maiorano, Monica Maria Pagliara, Maria Grazia Sammarco, Tommaso Dosa, Maurizio Martini, Guido Rindi, Emilio Bria, Maria Antonietta Blasi, Giampaolo Tortora, Giovanni Schinzari - Frontiers in Oncology 2019 被引用: 47

  19. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system

    著者: Guido Rindi, Günter Klöppel, Anne Couvelard, Paul Komminoth, Meike Körner, José Manuel Lopes, A. M. McNicol, Ola Nilsson, Aurel Perren, Aldo Scarpa, Jean‐Yves Scoazec, Bertram Wiedenmann - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2007 被引用: 954

  20. The 2010 WHO Classification of Digestive Neuroendocrine Neoplasms: a Critical Appraisal four years after Its Introduction

    著者: Guido Rindi, Gianluigi Petrone, Frediano Inzani - Endocrine Pathology 2014 被引用: 165

  21. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis

    著者: Emanuele Leoncini, Greta Carioli, Carlo La Vecchia, Stefania Boccia, Guido Rindi - Annals of Oncology 2015 被引用: 157

  22. Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms

    著者: Emanuele Leoncini, Paolo Boffetta, Michail Shafir, Katina Aleksovska, Stefania Boccia, Guido Rindi - Endocrine 2017 被引用: 155

  23. HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?

    著者: Francesco Bussu, Michela Sali, Roberto Gallus, Valerio Gaetano Vellone, Gian Franco Zannoni, Riccardo Autorino, N. Dinapoli, Rosaria Santangelo, R Martucci, C. Graziani, Francesco Miccichè, Giovanni Almadori, Jacopo Galli, Giovanni Delogu, Maurizio Sanguinetti, Guido Rindi, Vincenzo Valentini, Gaetano Paludetti - British Journal of Cancer 2013 被引用: 113

  24. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study

    著者: Guido Rindi, Ombretta Luinetti, Matteo Cornaggia, Carlo Capella, Enrico Solcia - Gastroenterology 1993 被引用: 643